Skip to main content
Andrew Evens

Hematology

Andrew Evens, DO, MS

Deputy Director for Clinical Services and Chief Physician Officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center; System Director of Medical Oncology and Oncology Lead, RWJBarnabas Health Medical Group; Associate Vice Chancellor for Clinical Innovation and Data Analytics, Rutgers Biomedical and Health Sciences

New Brunswick, NJ

Andrew M. Evens, DO, MBA, MSc, is a distinguished hematologist-oncologist specializing in lymphoid malignancies, including Hodgkin lymphoma, non-Hodgkin lymphoma (all types), and chronic lymphocytic leukemia. He treats patients with these conditions using advanced techniques such as cell therapy and autologous hematopoietic stem cell transplantation. As Deputy Director for Clinical Services and Chief Physician Officer at Rutgers Cancer Institute of New Jersey and the Jack & Sheryl Morris Cancer

...

30+

Years in Practice

Credentials

Board Certifications

  • Internal Medicine
  • Hematology
  • Medical Oncology

Education & Training

  • Chicago College of Osteopathic Medicine-Midwestern University — D.O., 1996
  • Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center — Fellowship, Hematology/Oncology

Peer Recognition

  • Castle ConnollyTop Doctor

    2017-2026 (10 years)

Clinical Focus

Subspecialties

Hematology & OncologyMedical Oncology

Conditions & Treatments

CAR-T Cell TherapyLeukemiaLymphomaMultiple MyelomaImmunotherapyPrecision OncologyMyelodysplastic SyndromeBone Marrow TransplantChemotherapyTargeted TherapyHematologic Malignancies

Practice Details

Hospital Affiliations

  • Rutgers Cancer Institute of New Jersey
  • Jack & Sheryl Morris Cancer Center
  • RWJBarnabas Health

Languages

English

Experience

30+ years in practice